Publication Name	World Journal of Clinical Oncology
Manuscript ID	12118
Country	United Kingdom

Received	2014-06-23 08:34
Peer-Review Started	2014-06-23 19:27
To Make the First Decision	2014-08-14 14:39
Return for Revision	2014-08-18 09:24
Revised	2014-08-19 00:00
Second Decision	2014-09-17 13:59
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2014-09-17 14:26
Articles in Press	2014-09-17 14:26
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2014-11-18 09:09
Publish the Manuscript Online	2014-12-11 14:23

ISSN	2218-4333 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Surgery
Manuscript Type	Editorial
Article Title	Emerging gene-based prognostic tools in early breast cancer: First steps to personalised medicine
Manuscript Source	Invited Manuscript
All Author List	Umar Wazir and Kefah Mokbel
Funding Agency and Grant Number	Funding Agency Grant Number Breast Cancer Hope Foundation (London, United Kingdom)
Corresponding Author	Kefah Mokbel, Professor, The London Breast Institute, Princess Grace Hospital, 45 Nottingham Place, London W1U 5NY, United Kingdom. kefahmokbel@hotmail.com
Key Words	Personalised medicine; Breast cancer; Prognosis; Polymerase chain reaction
Core Tip	Recurrence score, Prosigna and EndoPredict (EP) currently have the most convincing evidence available, of which Prosigna and EP have a significant degree of external validation. In terms of cost and turnover, EP has an advantage over its competitors, being designed to be performed at a local laboratory rather than at a central facility. The results of the results of the MINDACT and TailoRx trials are awaited.
Publish Date	2014-12-11 14:23
Citation	Wazir U, Mokbel K. Emerging gene-based prognostic tools in early breast cancer: First steps to personalised medicine. World J Clin Oncol 2014; 5(5): 795-799
URL	http://www.wjgnet.com/2218-4333/full/v5/i5/795.htm
DOI	http://dx.doi.org/10.5306/wjco.v5.i5.795

Full Article (PDF)	WJCO-5-795.pdf
Full Article (Word)	WJCO-5-795.doc
Manuscript File	12118-Review.doc
Answering Reviewers	12118-Answering reviewers.pdf
Copyright License Agreement	12118-Copyright assignment.pdf
Peer-review Report	12118-Peer review(s).pdf
Scientific Misconduct Check	12118-CrossCheck.jpg
Scientific Editor Work List	12118-Scientific editor work list.pdf